Orbital Signaling in Graves' Orbitopathy

Front Endocrinol (Lausanne). 2021 Nov 9:12:739994. doi: 10.3389/fendo.2021.739994. eCollection 2021.

Abstract

Graves' orbitopathy (GO) is a complex and poorly understood disease in which extensive remodeling of orbital tissue is dominated by adipogenesis and hyaluronan production. The resulting proptosis is disfiguring and underpins the majority of GO signs and symptoms. While there is strong evidence for the thyrotropin receptor (TSHR) being a thyroid/orbit shared autoantigen, the insulin-like growth factor 1 receptor (IGF1R) is also likely to play a key role in the disease. The pathogenesis of GO has been investigated extensively in the last decade with further understanding of some aspects of the disease. This is mainly derived by using in vitro and ex vivo analysis of the orbital tissues. Here, we have summarized the features of GO pathogenesis involving target autoantigens and their signaling pathways.

Keywords: IGF1R; TSAB; TSHR; adipogenesis; hyaluronan; thyroid eye disease.

Publication types

  • Review

MeSH terms

  • Graves Ophthalmopathy / metabolism*
  • Humans
  • Hyaluronic Acid / metabolism
  • Receptor, IGF Type 1 / metabolism*
  • Receptors, Thyrotropin / metabolism*
  • Signal Transduction / physiology*
  • Thyroid Gland / metabolism*

Substances

  • Receptors, Thyrotropin
  • Hyaluronic Acid
  • Receptor, IGF Type 1